EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia

Yi Xu, David J Baylink, Jeffrey Xiao, Lily Tran, Vinh Nguyen, Brandon Park, Ismael Valladares, Scott Lee, Kevin Codorniz, Laren Tan, Chien-Shing Chen iD, Hisham Abdel-Azim und 4 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yi Xu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, School of Medicine, Loma Linda University, Loma Linda, CA 92354, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Genome, Mitochondrial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Loma Linda University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) has a poor survival rate for both pediatric and adult patients due to its frequent relapse. To elucidate the bioenergetic principle underlying AML relapse, we investigated the transcriptional regulation of mitochondrial–nuclear dual genomes responsible for metabolic plasticity in treatment-resistant blasts. Both the gain and loss of function results demonstrated that NFκB2, a noncanonical transcription factor (TF) of the NFκB (nuclear factor kappa-light-chain-enhancer of activated B cells) family, can control the expression of TFAM (mitochondrial transcription factor A), which is known to be essential for metabolic biogenesis. Furthermore, genetic tracking and promoter assays revealed that NFκB2 is in the mitochondria and can bind the specific “TTGGGGGGTG” region of the regulatory D-loop domain to activate the light-strand promoter (LSP) and heavy-strand promoter 1 (HSP1), promoters of the mitochondrial genome. Based on our discovery of NFκB2′s novel function of regulating mitochondrial–nuclear dual genomes, we explored a novel triplet therapy including inhibitors of NFκB2, tyrosine kinase, and mitochondrial ATP synthase that effectively eliminated primary AML blasts with mutations of the FMS-related receptor tyrosine kinase 3 (FLT3) and displayed minimum toxicity to control cells ex vivo. As such, effective treatments for AML must include strong inhibitory actions on the dual genomes mediating metabolic plasticity to improve leukemia prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteGenome, MitochondrialHumansCell Line, TumorPromoter Regions, GeneticTranscription FactorsCell NucleusDNA-Binding ProteinsMitochondriaMitochondrial ProteinsGene Expression Regulation, Leukemic

Stichwörter der Autor:innen

AMLATPFLT3NFκB2NRF1TFAMgilteritinibmetabolismmitochondrion

Substanzen

Transcription FactorsDNA-Binding ProteinsMitochondrial Proteinsmitochondrial transcription factor A

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, School of Medicine, Loma Linda University, Loma Linda, CA 92354, USA.
  • Division Regenerative Medicine, Department of Medicine, School of Medicine, Loma Linda University, Loma Linda, CA 92354, USA.
  • Cancer Center, Loma Linda University, Loma Linda, CA 92354, USA.
  • Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, School of Medicine, Loma Linda University, Loma Linda, CA 92354, USA.
  • Division of Pulmonary, Critical Care, Hyperbaric and Sleep Medicine, Department of Medicine, School of Medicine, Loma Linda University, Loma Linda, CA 92354, USA.
  • Division of Transplant and Cell Therapy, Loma Linda University Cancer Center, Loma Linda, CA 92354, USA.

ORCID-Profile: Chien-Shing Chen

Förderung

  • Loma Linda University

Zitieren

APA

Xu, Y., Baylink, D. J., Xiao, J., Tran, L., Nguyen, V., Park, B., Valladares, I., Lee, S., Codorniz, K., Tan, L., Chen, C. S., Abdel-Azim, H., Reeves, M. E., Mirshahidi, H., Marcucci, G., & Cao, H. (2024). Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158532

Vancouver

Xu Y, Baylink DJ, Xiao J, Tran L, Nguyen V, Park B, et al. Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158532

BibTeX
@article{Xu2024,
  author = {Xu, Yi and Baylink, David J and Xiao, Jeffrey and Tran, Lily and Nguyen, Vinh and Park, Brandon and Valladares, Ismael and Lee, Scott and Codorniz, Kevin and Tan, Laren and Chen, Chien-Shing and Abdel-Azim, Hisham and Reeves, Mark E and Mirshahidi, Hamid and Marcucci, Guido and Cao, Huynh},
  title = {Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158532}
}
Kostenlos starten →